Coherent director updates filing on 3,911-share trade
Amended insider report for COHR adds previously omitted option-exercise shares and details same-day sale and charitable gift by a director.
Rhea-AI Filing Summary
COHERENT CORP. (COHR) received an amended insider report from director Enrico Digirolomo correcting a prior report to include common shares acquired upon option exercises that were previously omitted. The amendment updates the reported number of common shares beneficially owned immediately after the omitted acquisition.
On March 6, 2026, Digirolomo exercised options for 1,005 common shares at $49.90 per share and 2,906 common shares at $36.56 per share, and disposed of the corresponding option positions. On the same date, he acquired those 3,911 shares of common stock through the exercises, sold 3,911 common shares at $241.50 per share, and made a bona fide gift of 1,847 common shares to a donor advised fund. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,911 shares
Net Sell
6 txns
Insider
Digirolomo Enrico
Role
Director
Sold
3,911 shs ($945K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| derivative | Option (Right to Buy) F2 | 1,005 | $0.00 | $0.00 |
| derivative | Option (Right to Buy) F3 | 2,906 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,005 | $49.90 | $50K |
| Exercise | Common Stock | 2,906 | $36.56 | $106K |
| Sale | Common Stock | 3,911 | $241.50 | $945K |
| Gift | Common Stock F1 | 1,847 | $0.00 | $0.00 |
Holdings After Transaction:
Option (Right to Buy) — 0 contracts (Direct);
Common Stock — 19,510 shares (Direct)
Footnotes (3)
- F1. Reports the donation of 1,847 shares of common stock to a donor advised fund.
- F2. These options vested in four equal annual installments beginning on August 28, 2019.
- F3. These options vested in four equal annual installments beginning on August 28, 2020.
Key Figures
Options exercised at $49.90: 1,005 shares
Options exercised at $36.56: 2,906 shares
Common shares acquired via exercises: 3,911 shares
+5 more
8 metrics
Options exercised at $49.90
1,005 shares
Options on common stock exercised by the director on March 6, 2026 at $49.90 per share
Options exercised at $36.56
2,906 shares
Options on common stock exercised by the director on March 6, 2026 at $36.56 per share
Common shares acquired via exercises
3,911 shares
Total common shares received from option exercises on March 6, 2026
Common shares sold
3,911 shares
Common stock sold on March 6, 2026 at $241.50 per share
Sale price per share
$241.50 per share
Price for the 3,911 common shares sold on March 6, 2026
Shares gifted to donor advised fund
1,847 shares
Bona fide gift of common stock to a donor advised fund on March 6, 2026
Option expiration date (1,005-share grant)
August 28, 2028
Expiration date for options with a $49.90 exercise price
Option expiration date (2,906-share grant)
August 28, 2029
Expiration date for options with a $36.56 exercise price
Key Terms
bona fide gift, donor advised fund, beneficially owned, Option (Right to Buy)
4 terms
bona fide gift financial
"The report characterizes the transfer of 1,847 common shares as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
donor advised fund financial
"A footnote explains the donation of 1,847 shares of common stock to a donor advised fund."
A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.
beneficially owned financial
"The amendment updates the number of common shares beneficially owned immediately following the omitted acquisition."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Option (Right to Buy) financial
"The director held an Option (Right to Buy) that could be exercised for common stock."
FAQ
What does the amended Form 4/A for COHR correct for director Enrico Digirolomo?
The amendment adds common shares acquired through option exercises on March 6, 2026 that were inadvertently omitted earlier and updates the reported number of common shares beneficially owned immediately after that previously unreported acquisition. No other previously reported transactions are changed.
How many COHR options did Enrico Digirolomo exercise in this amended report?
On March 6, 2026, Enrico Digirolomo exercised options covering 1,005 common shares at $49.90 per share and 2,906 common shares at $36.56 per share, for a total of 3,911 shares of COHERENT CORP. common stock acquired through option exercises.
Did the COHR director make any gifts of stock in this insider filing?
Yes. The report states a bona fide gift of 1,847 shares of COHERENT CORP. common stock on March 6, 2026. A footnote explains that this represents a donation of 1,847 shares to a donor advised fund.
Are the COHR insider transactions linked to a Rule 10b5-1 trading plan?
No. The amended insider report indicates that these March 6, 2026 transactions by director Enrico Digirolomo were not made under a Rule 10b5-1 trading plan, meaning there is no reported pre-arranged trading plan governing their timing.
What happens to the options after the COHR director’s exercises on March 6, 2026?
The report shows the disposition of option positions for 1,005 and 2,906 underlying shares on March 6, 2026. These options had exercise prices of $49.90 and $36.56 per share and were scheduled to expire on August 28, 2028 and August 28, 2029, respectively.
AI-generated analysis. How Rhea-AI works. Not financial advice.
